The Delhi High Court has reserved its judgment in a significant arbitration case. Japanese drug maker Daiichi Sankyo is seeking to enforce a decade-old award of ₹5,200 crore against former Fortis promoters. The case involves allegations of fraud in the sale of Ranbaxy Laboratories. Daiichi aims to recover its dues, while Fortis disputes liability for shrinking assets.